Shahed Badiyan

Radiation Oncologist, Director of Clinical Adaptive Therapy @UTSW

[David Sher @DavidSherMD]

Nice article, and I agree. The recommendations:

“Language in health care has ethical and practical implications. Physicians should be referred to as physicians, not providers. Also, when describing professionals with varied credentials who care for patients, the terms clinicians or health care professionals, not providers, should be used.”

Physicians Are Not Providers: The Ethical Significance of Names in Health Care: A Policy Paper From the American College of Physicians | Annals of Internal Medicine

https://t.co/P5TdiDa0FM

[Hooman M. Melamed MD FAAOS @DrHMelamed]

Can somebody please tell me why is @cnn interviewing this EVIL monster?

Do they know that this guy murdered his own son?

His son spoke out against the regime and his own father, and then this monster lured him back to Iran just to murder him.

[UTSW Radiation Oncology @UTSW_RadOnc]

Chelsea Bolton, one of our recent interns, will present her Phase II GammaPod 5-Fraction Trial abstract at @ASTRO_org later this year. Her study shows comparable cosmetic outcomes across racial and age groups after dose-escalated S-PBI. It will also be published in @IJROBP.

[Shahed Badiyan @BadiyanMD]

@NiuSanford @lauren_henke @OncoAlert Did they still radiate the entire mesorectum including all the nodes it contains and just spare the internal iliac nodes or did they spare the mesorectum too?

[Dr. Nina Niu Sanford @NiuSanford]

Neo-CRAG: Ph3 RCT (n=620, gastric/GEJ) - adding neoadj chemoRT to peri-op XELOX improved OS (68 v 38 mo).

Limitation=non-FLOT, BUT still relevant IMO b/c:

1) DFS/OS benefit substantial.
2) Improvements in pCR, downstg, LRR supports plausible RT effect on OS. #ASCO26 @OncoAlert

[David Sher @DavidSherMD]

Absolutely terrific work by @DrSymYoung to report the long-term outcomes of our INRT experience from two prospective trials (INRT-AIR and DARTBOARD).

Short version: with long-term follow-up (median 5.2 years for INRT-AIR, 3 years for DARTBOARD), we've seen zero solitary elective nodal recurrences.

Longer version: ESTRO has highlighted novel approaches to managing the elective neck in HNSCC, and I believe the future will be very different than the present. Current ENI fields deliver the majority of the integral dose to patients and contribute substantially to critical structures (swallowing and xerostomia OARs). Minimizing ENI dose and volume may meaningfully improve the short- and especially long-term tolerance of radiotherapy.

A few more thoughts on our INRT paradigm below:

[UTSW Radiation Oncology @UTSW_RadOnc]

A great turnout and experience! Over the last few days, our Brachytherapy Training Program, led by experts in our Department, delivered hands-on training, expert guidance, and valuable learning. Grateful to our attendees and everyone who helped make it another huge success!

[David Sher @DavidSherMD]

Medical students interested in radiation oncology: come to Dallas for a clerkship!

Our department is a great opportunity for students to learn about cutting-edge treatments in the field (adaptive radiotherapy, direct-to-unit treatments, MR-only sim, PULSAR, to name a few)!

[John Christodouleas @Xristodouleas]

Arm 1 based on UTSW experience: https://t.co/4VqIGj5u52

Arm 2 based on UNITED Trial: https://t.co/F1kAWQVhMd

Arm 3: will use EORTC margins.

[UTSW Radiation Oncology @UTSW_RadOnc]

Join us for our rotation blocks. Registration is now open!

Register and learn more here ➡️: https://t.co/rAxHzKNRyV

[UTSW Radiation Oncology @UTSW_RadOnc]

Drs. Neil Desai, Nina Sanford, Arnold Pompos, and Xiaofeng Yang closed our Adaptive Radiotherapy Symposium with insightful talks. Thank you to our speakers, organizers, and attendees for making this event a success! The future of ART is bright and is rapidly evolving.

[UTSW Radiation Oncology @UTSW_RadOnc]

A wonderful start to Day 2 of our Adaptive Radiotherapy Symposium with talks from Drs. Di Yan, Michalis Aristophanous, Francesca Albertini, and Heiko Enderling, followed by a Q&A panel with all four speakers. Great discussion and insights!

[UTSW Radiation Oncology @UTSW_RadOnc]

We’re officially underway at our Adaptive Radiotherapy Symposium! Excited to welcome an incredible group of speakers and dive into two days of insightful talks, presentations, and collaboration. Looking forward to the conversations and learning ahead!

[UTSW Radiation Oncology @UTSW_RadOnc]

A successful afternoon of talks and presentations here on day one at our Adaptive Radiotherapy Symposium! Many engaging in‑depth discussions covering key developments in adaptive radiation therapy.

[Dr. Nina Niu Sanford @NiuSanford]

Phase 2 RT trials often “succeed” but rarely translate. Of coop group trials, 54% met endpts, but only 17% advanced to Ph3.

We propose strategies to better align Ph2 design w decision-relevant outcomes

Paper out w @DavidSherMD in @JCOOP_ASCO. @OncoAlert

https://t.co/iD07TBvS8r

[Masih Alinejad 🏳️ @AlinejadMasih]

“Speed up the executions and confiscation of property.”

This is the order issued by Gholam-Hossein Mohseni-Eje’i. It is nothing less than a death sentence for the children of Iran and a green light to plunder the property of its people.

After its humiliating setbacks against the United States and Israel, the Islamic Republic of Iran has once again turned its blade inward, sharpening repression against its own citizens and accelerating executions to compensate for its failures.

We are in a full-scale war!

#Iran
#DigitalBlackOutIran‌

[NonsparseOncologist @5_utr]

@alexhotca @jryckman3 @RenoHemonc @ArndtVogel @HEP_Journal IRE: invasive, technically finicky, mediocre LC data, device-company driven.

SBRT: non-invasive, reproducible, years of outcome data, no anesthesia.

Why are we still having this conversation?

[Alex Hotca, MD @alexhotca]

@RenoHemonc @jryckman3 @ArndtVogel @HEP_Journal Yes this needs to stop. There are no studies to show histotripsy’s utility in cholangio and 1 year data LC in general not good. We have to stop giving false hope to patients! IRE study combined with IO again unnecessary. We have better modalities with better LC as per @jryckman3

[John Christodouleas @Xristodouleas]

Hey @mr_linac , treating near the esophagus? Check out this smart innovation from @UTSW_RadOnc

Patients drink the "UTSW Pineapple Mix" to clearly visualize the esophagus on T2 SPIR. 🍍

Recipe:
1 packet Thick-It Original
2.5 oz 100% pineapple juice

Thanks to Drs. Westover and Visak for sharing!

#RadOnc #MedPhys @MHLinPhD @BobTimmermanMD @ArnoldPompos @GeinaIskander

[UTSW Radiation Oncology @UTSW_RadOnc]

We are ONE week away! Attend our ART Symposium to learn practical, evidence‑based strategies you can apply right away, from core concepts to real‑world implementation.

💻 Attend in person, virtually, or on demand
☑️ CME credits available

Register now: https://t.co/K3N2GPSJmh